The global contrast media injectors market is expected to reach $1.4 billion by 2025, growing at a compound annual ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
The continuing search for advantages to improve workflow has radiology departments constantly searching for new ...
February 28, 2018 — Guerbet will present its new Contrast&Care application, as well as other contrast media offerings ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) used ...
February 7, 2018 — The American College of Radiology (ACR) introduced a new contrast reaction card that summarizes ...
January 30, 2018 — Bracco Diagnostics Inc. announced the labeling of its contrast agent MultiHance has obtained U.S ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced ...
The Radiological Association of North America's (RSNA) 2017 conference will be remembered as the year artificial ...
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
January 9, 2018 – Competitive male triathletes face a higher risk of a potentially harmful heart condition called ...
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of ...
The U.S. Food and Drug Administration (FDA) announced in a new drug safety communication is this week that it is ...
With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their ...
Over the past couple years covering the news about gadolinium-based contrast agent (GBCA) retention in the brain, skin ...
December 12, 2017 — Brainlab announced U.S. Food and Drug Administration (FDA) clearance of its Contrast Clearance ...
December 11, 2017 — Sectra recently announced the global introduction of gadolinium tracking in its dose monitoring ...
Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, discussed MRI ...
October 10, 2017 — Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de ...
Over the past decade, several clinical studies have shown gadolinium-based magnetic resonance imaging (MRI) contrast ...
September 12, 2017 — The U.S. Food and Drug Administration’s (FDA) Medical Imaging Drugs Advisory Committee (MIDAC) ...
September 7, 2017 — The U.S. Food and Drug Administration (FDA) held a meeting of the Medical Imaging Drugs Advisory ...